Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trialHiddo J.L. Heerspink, Toby Coates, Stewart Bieler et al.|The Lancet|2023Cited by 214
Kidney dysfunction in renal amyloidosis: does the complement system play a part in hereditary ATTRV30M and iatrogenic ATTR amyloidosis?Ana Carina Ferreira, Fernando Nolasco|Portuguese Journal of Nephrology & Hypertension|2019Cited by 0